Group One Trading, L.P.
- SEC CIK
- 0000932540
- Latest filing
- Aug 13, 2026
ATOS holding history
Atossa Therapeutics, Inc. in every 13F filed by Group One Trading, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATOS overviewAll 13F holders of ATOSFull Q2 2026 holdings
- Shares (Q2 2026)
- 54
- Value
- $104
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 54 | $104 | <0.1% | −555−91.1% | Reduced | Holders |
| Q1 2026 | 609 | $3.20K | <0.1% | +165+37.1% | AddedConverted for a 1-for-15 split | Holders |
| Q4 2025 | 6,662 | $3.93K | <0.1% | +6,662 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −193−100.0% | Sold out | Holders |
| Q2 2025 | 193 | $160 | <0.1% | −56,014−99.7% | Reduced | Holders |
| Q1 2025 | 56,207 | $37.8K | <0.1% | +42,777+318.5% | Added | Holders |
| Q4 2024 | 13,430 | $12.7K | <0.1% | +13,430 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −24,198−100.0% | Sold out | Holders |
| Q2 2024 | 24,198 | $28.8K | <0.1% | −82,510−77.3% | Reduced | Holders |
| Q1 2024 | 106,708 | $192.1K | <0.1% | −8,541−7.4% | Reduced | Holders |
| Q4 2023 | 115,249 | $101.4K | <0.1% | −15,486−11.8% | Reduced | Holders |
| Q3 2023 | 130,735 | $96.3K | <0.1% | +56,100+75.2% | Added | Holders |
| Q2 2023 | 74,635 | $94.0K | <0.1% | +10,607+16.6% | Added | Holders |
| Q1 2023 | 64,028 | $46.4K | <0.1% | −73,138−53.3% | Reduced | Holders |
| Q4 2022 | 137,166 | $72.5K | <0.1% | +115,025+519.5% | Added | Holders |
| Q3 2022 | 22,141 | $18.0K | <0.1% | +22,141 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −1,644,488−100.0% | Sold out | Holders |
| Q2 2021 | 1,644,488 | $10.4M | 0.2% | +1,644,488 | New | Holders |